David Teachey is an Oncology physician affiliated with Children's Hospital of Philadelphia. OpenAlex indexes 653 publications with 28,908 citations (h-index 70); ClinicalTrials.gov lists 1 registered study matched to this name. By OpenAlex citation count, this profile ranks in the top 5% of Pediatric Hematology-Oncology profiles in the findmyKOL directory.
Overview
Scholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex, matched via ORCID.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
3401 Civic Center Blvd
Children'S Hospital Of Philadelphia - Hem/onc
Philadelphia, PA 191044319
Telephone
215-590-3535Registry record last updated 16 Apr 2013.
Clinical trials
- Tocilizumab and Hemophagocytic Lymphohistiocytosis (HLH)
Sponsor: Children's Hospital of Philadelphia
- Sirolimus for Autoimmune Disease of Blood Cells
Sponsor: Children's Hospital of Philadelphia
Registered studies on ClinicalTrials.gov where the overall official or a site investigator name-matches this physician, confirmed against known institution/geography. Latest few shown; the full list is part of the full profile.
Industry payments
5 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:
- Amgen Inc.Program year20255 payments
- SOBI, INCProgram year20252 payments
- Merck Sharp & Dohme LLCProgram year20252 payments
Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.
NIH funding
5 NIH research awards on record, funded 2011–2026 per NIH RePORTER. The latest:
- Characterization and targeting of HSPC-like blasts in high-risk leukemias
Children'S Hosp of Philadelphia
FY2026$744,511R01CA303081 - Improving risk allocation and developing novel therapies for children with T-ALL and T-LL
Children'S Hosp of Philadelphia
FY2026$737,350R01CA193776 - Improving risk allocation and developing novel therapies for children with T-ALL and T-LL
Children'S Hosp of Philadelphia
FY2025$737,926R01CA193776
Awards in the NIH RePORTER records where a principal investigator name matches this physician at an organization in their practice state. Latest award years shown; each row links to the project record on RePORTER.
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
- Blinatumomab in Standard-Risk B-Cell Acute Lymphoblastic Leukemia in Children
New England Journal of Medicine
2024 - Immune Effector Cell-Associated Hemophagocytic Lymphohistiocytosis-Like Syndrome
Biology of Blood and Marrow Transplantation
2023
Similar KOLs
Other experts from the same institution or the same specialty.
Stephan Grupp, MD
Children's Hospital of Philadelphia
John Maris, MD
Children's Hospital of Philadelphia
Stephen Hunger, MD
Children's Hospital of Philadelphia
Jonathan Spergel, MD
Children's Hospital of Philadelphia
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments — shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”